|
| | pyridoxamine Basic information |
| Product Name: | pyridoxamine | | Synonyms: | 4-(azaniumylmethyl)-5-(hydroxymethyl)-2-methylpyridin-3-olate;4-(aminomethyl)-5-(hydroxymethyl)-2-methyl-pyridin-3-ol;3-Hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinemethanamine;4-Aminomethyl-5-hydroxy-6-methyl-3-pyridinemethanol;Pyridorin;4-(aminomethyl)-2-methyl-5-methylol-pyridin-3-ol;PyridoxaMine-d4;Pyridoxylamine | | CAS: | 85-87-0 | | MF: | C8H12N2O2 | | MW: | 168.19 | | EINECS: | 201-640-5 | | Product Categories: | | | Mol File: | 85-87-0.mol |  |
| | pyridoxamine Chemical Properties |
| Melting point | 193-193.5 °C | | Boiling point | 460.1±40.0 °C(Predicted) | | density | 1.282±0.06 g/cm3(Predicted) | | storage temp. | Hygroscopic, Refrigerator, under inert atmosphere | | solubility | DMSO (Slightly), Methanol (Slightly) | | pka | 9.98±0.10(Predicted) | | form | Solid | | color | Pale Yellow | | Stability: | Hygroscopic |
| | pyridoxamine Usage And Synthesis |
| Definition | ChEBI: Pyridoxamine is a monohydroxypyridine that is pyridine substituted by a hydroxy group at position 3, an aminomethyl group at position 4, a hydroxymethyl group at position 5 and a methyl group at position 2. The 4-aminomethyl form of vitamin B6, it is used (in the form of the hydrochloride salt) for treatment of diabetic nephropathy. It has a role as a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a plant metabolite, a mouse metabolite, an iron chelator and a nephroprotective agent. It is a hydroxymethylpyridine, a monohydroxypyridine, an aminoalkylpyridine and a vitamin B6. It is a conjugate base of a pyridoxaminium(1+). |
| | pyridoxamine Preparation Products And Raw materials |
|
